CD4 and myeloid sarcoma: In contrast to CD4+CD20- T cells, CD4+CD20+ T cells were able to induce a fast and strong expression of both adhesion molecules on brain endothelial cells, pinpointing this as a potentially major mechanism of CD4+CD20+ T cells to advance inflammation in patients with MS and other inflammatory CNS diseases.